MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
Ignyta (NASDAQ:RXDX)
Organization & Developments: Ignyta
Parents
Ignyta (NASDAQ:RXDX)
Children
2017: Biotech Forum Daily Digest: Spotlighting Ignyta's Big Recent Rally
2017: Ignyta: Buy The Dip - Ignyta, Inc. (NASDAQ:RXDX)
2017: Ignyta: ROS1 Lung Cancer Update Causing Shares To Break Out - Ignyta, Inc. (NASDAQ:RXDX)
Developing precision medicine with integrated Rx/Dx solutions for cancer patients
Ignyta is a scientifically driven biotechnology company catalyzing personalized medicine in autoimmune diseases.
Oncology precision medicine biotechnology company
Their goals are to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions
Jumps
*Key People: Ignyta
Finance & Acquisitions: Ignyta